Hematological Diseases and Therapies
ISSN: 2577-1418
Impact Factor: 3.02
Research Article
Biosimilar Filgrastim (Nivestim®) in the Treatment and Prevention of Chemotherapy-Induced Neutropenia: Results of the NEXT Observational Study
Frederic Maloisel, Stephane Lepretre, Didier Kamioner, Christian Berthou, Laurent Cals
Hematological Diseases and Therapies